Literature DB >> 2891616

Maternal immunization with P fimbriae for the prevention of neonatal pyelonephritis.

M B Kaack1, J A Roberts, G Baskin, G M Patterson.   

Abstract

Rhesus monkeys (Macaca mulatta) were immunized with purified P fimbriae from Escherichia coli during the last trimester of pregnancy. Infants born of these mothers were compared with those from nonimmunized rhesus mothers. A delay in the onset of renal disease after bladder infection showed protection from passive immunization. This was associated with a high antibody titer in serum. In addition to delayed onset of renal infection, a decreased number of immunized monkeys developed pyelonephritis.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2891616      PMCID： PMC259223          DOI： 10.1128/iai.56.1.1-6.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Chemical differences of adult, fetal and hypogammaglobulinemic IgG immunoglobulins.

Authors:  A C Wang; W P Faulk; M A Stuckey; H H Fudenberg
Journal:  Immunochemistry       Date:  1970-08

3.  New Method for isolation of immunologically pure pili from Escherichia coli.

Authors:  T K Korhonen; E L Nurmiaho; H Ranta; C S Edén
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

4.  Prevention of pyelonephritis by immunization with P-fimbriae.

Authors:  J A Roberts; K Hardaway; B Kaack; E N Fussell; G Baskin
Journal:  J Urol       Date:  1984-03       Impact factor: 7.450

5.  Decreased incidence of urinary tract infections in circumcised male infants.

Authors:  T E Wiswell; F R Smith; J W Bass
Journal:  Pediatrics       Date:  1985-05       Impact factor: 7.124

6.  Experimental pyelonephritis in the monkey. II. The prognostic value of radionuclide evaluation of the urinary tract.

Authors:  J A Roberts; G J Domingue
Journal:  Invest Urol       Date:  1975-03

7.  Lymphocyte surface IgD and IgM in non-human primates.

Authors:  L N Martin; G A Leslie; R Hindes
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

8.  Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using deae cellulose and protein A-sepharose.

Authors:  L N Martin
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

9.  Experimental pyelonephritis. V. Functional characteristics of pyelonephritis.

Authors:  K L Janson; J A Roberts
Journal:  Invest Urol       Date:  1978-03

10.  Immunology of pyelonephritis in the primate model: live versus heat-killed bacteria.

Authors:  J A Roberts; G J Domingue; L N Martin; J C Kim
Journal:  Kidney Int       Date:  1981-02       Impact factor: 10.612
View more
  10 in total

1.  P-fimbriae vaccines. I. Cross reactive antibodies to heterologous P-fimbriae.

Authors:  M B Kaack; A Pere; T K Korhonen; S B Svenson; J A Roberts
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

2.  P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.

Authors:  J A Roberts; M B Kaack; G Baskin; T K Korhonen; S B Svenson; J Winberg
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

Review 3.  Applications from bacterial adhesion and biofilm studies in relation to urogenital tissues and biomaterials: a review.

Authors:  G Reid
Journal:  J Ind Microbiol       Date:  1994-03

4.  Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Authors:  J R Johnson; A L Stell; F Scheutz; T T O'Bryan; T A Russo; U B Carlino; C Fasching; J Kavle; L Van Dijk; W Gaastra
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 5.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity.

Authors:  R Tewari; T Ikeda; R Malaviya; J I MacGregor; J R Little; S J Hultgren; S N Abraham
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.

Authors:  J A Roberts; M B Kaack; G Baskin; S B Svenson
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 8.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

9.  Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.

Authors:  James A Roberts; M Bernice Kaack; Gary Baskin; Matthew R Chapman; David A Hunstad; Jerome S Pinkner; Scott J Hultgren
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

10.  Solid-phase binding of clinical isolates of Escherichia coli expressing different piliation phenotypes. Effect of glycosaminoglycans.

Authors:  F Busolo; L Francescon; F Aragona; F Pagano
Journal:  Urol Res       Date:  1995
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.